Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration

Gastroenterology
N HudsonC J Hawkey

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) are strongly associated with gastroduodenal ulceration. How to manage patients with NSAID-associated ulcers is a common clinical dilemma. High-dose famotidine in the healing and maintenance of NSAID-associated gastroduodenal ulceration was therefore evaluated. One hundred four patients with rheumatoid or osteoarthritis who had gastroduodenal ulceration received famotidine, 40 mg twice daily. Sixteen patients stopped and 88 continued their NSAID treatment. Ulcer healing was assessed endoscopically at 4 and 12 weeks. Seventy-eight NSAID users with healed ulcers were then randomized to receive 40 mg twice daily famotidine or placebo and underwent endoscopy at 4, 12, and 24 weeks. Cumulative ulcer healing rates at 12 weeks were 89.0% (95% confidence interval [CI], 82.3%-95.7%) for patients who continued NSAID treatment and 100% (95% CI, 82.9%-100.0%) for those who stopped. The subsequent estimated cumulative gastroduodenal ulcer relapse over 6 months for NSAID users who took placebo was 53.5% (95% CI, 36.6%-70.3%). This was reduced to 26.0% (12.1%-39.9%) in patients taking famotidine (P = 0.011). High-dose famotidine is effective ulcer healing therapy in patients who stop or continue NS...Continue Reading

Associated Clinical Trials

Apr 16, 2015·Ping-I (William) Hsu, M.D.Ping-I (William) Hsu, M.D.

Citations

Sep 4, 2004·Annals of the Rheumatic Diseases·L S LohmanderUNKNOWN STAR Multinational Study Group
Dec 7, 2013·Arthritis Research & Therapy·Anne Tuskey, David Peura
Jul 21, 2012·World Journal of Gastrointestinal Endoscopy·Haruka FujinamiToshiro Sugiyama
Jun 15, 2011·World Journal of Cardiology·Shoa-Lin LinJaw-Wen Chan
Mar 1, 2000·Modern Rheumatology·D Y Graham
Feb 4, 2006·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Jørgen Naesdal, Kurt Brown
Aug 26, 1998·The American Journal of Medicine·B Cryer, M B Kimmey
Jul 2, 1999·The American Journal of Medicine·J B Raskin
Dec 5, 2003·Alimentary Pharmacology & Therapeutics·M C J M SturkenboomJ L Goldstein
Jan 16, 2008·Alimentary Pharmacology & Therapeutics·N D Yeomans, J Naesdal
Aug 15, 2013·Pain Practice : the Official Journal of World Institute of Pain·Robert Andrew MoorePaul Emery
Jun 14, 2001·Best Practice & Research. Clinical Gastroenterology·F K Chan, J J Sung
Apr 5, 2000·Baillière's Best Practice & Research. Clinical Gastroenterology·C J Hawkey
Nov 26, 1999·Alimentary Pharmacology & Therapeutics·L R FitzpatrickT Le
Dec 13, 2016·Expert Opinion on Pharmacotherapy·Tushar SharmaPaul A Gurbel
Jun 24, 2004·The Annals of Pharmacotherapy·Ryan B Jacobsen, Beth Bryles Phillips
Feb 7, 2001·Gastroenterology Clinics of North America·M S Cappell, J R Schein
Feb 24, 2001·Gastroenterology Clinics of North America·N D YeomansC J Hawkey
Jan 10, 2003·The Cochrane Database of Systematic Reviews·A RostomJ McGowan
Jun 23, 2001·The American Journal of Gastroenterology·M A Blank, A B Thomson
May 2, 2002·Journal of Gastroenterology and Hepatology·Neville D Yeomans
Feb 26, 2009·The American Journal of Gastroenterology·Frank L LanzaUNKNOWN Practice Parameters Committee of the American College of Gastroenterology
Jan 27, 2019·Journal of Gastroenterology and Hepatology·Yingying GongLishou Xiong
Sep 30, 2006·Nature Clinical Practice. Gastroenterology & Hepatology·Francis K L Chan
Jan 18, 2006·Digestive Diseases and Sciences·Raffaella ScagliariniPaolo Pazzi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.